BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33102403)

  • 1. Neonatal Diabetes Mellitus.
    Beltrand J; Busiah K; Vaivre-Douret L; Fauret AL; Berdugo M; Cavé H; Polak M
    Front Pediatr; 2020; 8():540718. PubMed ID: 33102403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
    Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H;
    Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal diabetes mellitus: a disease linked to multiple mechanisms.
    Polak M; Cavé H
    Orphanet J Rare Dis; 2007 Mar; 2():12. PubMed ID: 17349054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation.
    Ahn SY; Kim GH; Yoo HW
    Korean J Pediatr; 2015 Aug; 58(8):309-12. PubMed ID: 26388896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal hyperglycaemia and abnormal development of the pancreas.
    Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
    Best Pract Res Clin Endocrinol Metab; 2008 Feb; 22(1):17-40. PubMed ID: 18279778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Diabetes: Case Report of a 9-Week-Old Presenting Diabetic Ketoacidosis Due to an Activating
    Sood S; Landreth H; Bustinza J; Chalmers L; Thukaram R
    J Investig Med High Impact Case Rep; 2017; 5(1):2324709617698718. PubMed ID: 28540314
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early onset diabetes mellitus].
    Busiah K; Vaivre-Douret L; Yachi C; Cavé H; Polak M
    Arch Pediatr; 2013 Dec; 20 Suppl 4():S117-26. PubMed ID: 24360362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
    Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation.
    Ozsu E; Giri D; Seymen Karabulut G; Senniappan S
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1403-1406. PubMed ID: 27849623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Neonatal Diabetes Mellitus in a Very Preterm Infant due to ABCC8 Mutation.
    Piccini B; Coviello C; Drovandi L; Rosangela A; Monzali F; Casalini E; Giglio S; Toni S; Dani C
    AJP Rep; 2018 Jan; 8(1):e39-e42. PubMed ID: 29527407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsing diabetes can result from moderately activating mutations in KCNJ11.
    Gloyn AL; Reimann F; Girard C; Edghill EL; Proks P; Pearson ER; Temple IK; Mackay DJ; Shield JP; Freedenberg D; Noyes K; Ellard S; Ashcroft FM; Gribble FM; Hattersley AT
    Hum Mol Genet; 2005 Apr; 14(7):925-34. PubMed ID: 15718250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T; Vedovato N; Patel K; Thomas N; Finn R; Männikkö R; Chakera AJ; Flanagan SE; Shepherd MH; Ellard S; Ashcroft FM; Hattersley AT
    Diabetologia; 2016 Jun; 59(6):1162-6. PubMed ID: 27033559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic paternal uniparental isodisomy and an ABCC8 gene mutation in a patient with permanent neonatal diabetes and hemihypertrophy.
    Shield JP; Flanagan SE; Mackay DJ; Harries LW; Proks P; Girard C; Ashcroft FM; Temple IK; Ellard S
    Diabetes; 2008 Jan; 57(1):255-8. PubMed ID: 17942821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
    Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
    Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
    Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
    Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
    Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNJ11 activating mutations cause both transient and permanent neonatal diabetes mellitus in Cypriot patients.
    Ioannou YS; Ellard S; Hattersley A; Skordis N
    Pediatr Diabetes; 2011 Mar; 12(2):133-7. PubMed ID: 21352428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.